A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients

Clinical trial NCT04501276 · COMPLETED

Trial details

NCT number: NCT04501276
Sponsor: Adagene Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced/Metastatic Solid Tumors

Start date: 2020-09-23
Primary completion: 2024-01-17
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.